TY - JOUR AU - Siegel, R. L. AU - Miller, K. D. AU - Jemal, A. PY - 2018 DA - 2018// TI - Cancer statistics, 2018 JO - CA Cancer J Clin VL - 68 ID - Siegel2018 ER - TY - JOUR AU - Francis, J. A. AU - Eiriksson, L. AU - Dean, E. AU - Sebastianelli, A. AU - Bahoric, B. AU - Salvador, S. PY - 2019 DA - 2019// TI - No. 370-Management of squamous cell cancer of the vulva JO - J Obstet Gynaecol Can VL - 41 ID - Francis2019 ER - TY - STD TI - SEER Cancer Statistics Factsheets: Vulvar Cancer. Bethesda, MD: National Cancer Institute. http://seer.cancer.gov/statfacts/html/vulva.html. Accessed 8 Feb 2019. UR - http://seer.cancer.gov/statfacts/html/vulva.html ID - ref3 ER - TY - JOUR AU - Cormio, G. AU - Loizzi, V. AU - Gissi, F. PY - 2009 DA - 2009// TI - Cisplatin and vinorelbine chemotherapy in recurrent vulvar carcinoma JO - Oncology VL - 77 ID - Cormio2009 ER - TY - JOUR AU - Witteveen, P. O. AU - Velden, J. AU - Vergote, I. PY - 2009 DA - 2009// TI - Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group) JO - Ann Oncol VL - 20 ID - Witteveen2009 ER - TY - JOUR AU - Horowitz, N. S. AU - Olawaiye, A. B. AU - Borger, D. R. PY - 2012 DA - 2012// TI - Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva JO - Gynecol Oncol VL - 127 ID - Horowitz2012 ER - TY - JOUR AU - Forner, D. M. AU - Lampe, B. PY - 2012 DA - 2012// TI - Exenteration in the treatment of Stage III/IV vulvar cancer JO - Gynecol Oncol VL - 124 ID - Forner2012 ER - TY - JOUR AU - Miller, B. AU - Morris, M. AU - Levenback, C. AU - Burke, T. W. AU - Gershenson, D. M. PY - 1995 DA - 1995// TI - Pelvic exenteration for primary and recurrent vulvar cancer JO - Gynecol Oncol VL - 58 ID - Miller1995 ER - TY - JOUR AU - Thigpen, J. T. AU - Blessing, J. A. AU - Homesley, H. D. AU - Lewis, G. C. PY - 1986 DA - 1986// TI - Phase II trials of cisplatin and piperazinedione in advanced or recurrent squamous cell carcinoma of the vulva: a Gynecologic Oncology Group Study JO - Gynecol Oncol VL - 23 ID - Thigpen1986 ER - TY - JOUR AU - Han, S. C. AU - Kim, D. H. AU - Higgins, S. A. AU - Carcangiu, M. L. AU - Kacinski, B. M. PY - 2000 DA - 2000// TI - Chemoradiation as primary or adjuvant treatment for locally advanced carcinoma of the vulva JO - Int J Radiat Oncol Biol Phys VL - 47 ID - Han2000 ER - TY - JOUR AU - Moore, D. H. AU - Ali, S. AU - Koh, W. J. PY - 2012 DA - 2012// TI - A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group study JO - Gynecol Oncol VL - 124 ID - Moore2012 ER - TY - JOUR AU - Doorn, H. C. AU - Ansink, A. AU - Verhaar-Langereis, M. AU - Stalpers, L. PY - 2006 DA - 2006// TI - Neoadjuvant chemoradiation for advanced primary vulvar cancer JO - Cochrane Database Syst Rev UR - https://doi.org/10.1002/14651858.CD003752.pub2 DO - 10.1002/14651858.CD003752.pub2 ID - Doorn2006 ER - TY - JOUR AU - Gill, B. S. AU - Bernard, M. E. AU - Lin, J. F. PY - 2015 DA - 2015// TI - Impact of adjuvant chemotherapy with radiation for node-positive vulvar cancer: a National Cancer Data Base (NCDB) analysis JO - Gynecol Oncol VL - 137 ID - Gill2015 ER - TY - JOUR AU - Kelland, L. PY - 2007 DA - 2007// TI - The resurgence of platinum-based cancer chemotherapy JO - Nat Rev Cancer VL - 7 ID - Kelland2007 ER - TY - JOUR AU - Todd, R. C. AU - Lippard, S. J. PY - 2009 DA - 2009// TI - Inhibition of transcription by platinum antitumor compounds JO - Metallomics VL - 1 ID - Todd2009 ER - TY - JOUR AU - Lesterhuis, W. J. AU - Punt, C. J. AU - Hato, S. V. PY - 2011 DA - 2011// TI - Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice JO - J Clin Invest VL - 121 ID - Lesterhuis2011 ER - TY - JOUR AU - Ramakrishnan, R. AU - Assudani, D. AU - Nagaraj, S. PY - 2010 DA - 2010// TI - Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice JO - J Clin Invest VL - 120 ID - Ramakrishnan2010 ER - TY - JOUR AU - Hato, S. V. AU - Vries, I. J. AU - Lesterhuis, W. J. PY - 2012 DA - 2012// TI - STATing the importance of immune modulation by platinum chemotherapeutics JO - Oncoimmunology VL - 1 ID - Hato2012 ER - TY - JOUR AU - Gong, J. AU - Le, T. Q. AU - Massarelli, E. AU - Hendifar, A. E. AU - Tuli, R. PY - 2018 DA - 2018// TI - Radiation therapy and PD-1/PD-L1 blockade: the clinical development of an evolving anticancer combination JO - J Immunother Cancer VL - 6 ID - Gong2018 ER - TY - JOUR AU - Martins, I. AU - Kepp, O. AU - Schlemmer, F. PY - 2011 DA - 2011// TI - Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress JO - Oncogene VL - 30 ID - Martins2011 ER - TY - JOUR AU - Obeid, M. AU - Panaretakis, T. AU - Joza, N. PY - 2007 DA - 2007// TI - Calreticulin exposure is required for the immunogenicity of gamma-irradiation and UVC light-induced apoptosis JO - Cell Death Differ VL - 14 ID - Obeid2007 ER - TY - JOUR AU - Verbrugge, I. AU - Hagekyriakou, J. AU - Sharp, L. L. PY - 2012 DA - 2012// TI - Radiotherapy increases the permissiveness of established mammary tumors to rejection by immunomodulatory antibodies JO - Cancer Res VL - 72 ID - Verbrugge2012 ER - TY - JOUR AU - Zeng, J. AU - See, A. P. AU - Phallen, J. PY - 2013 DA - 2013// TI - Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas JO - Int J Radiat Oncol Biol Phys VL - 86 ID - Zeng2013 ER - TY - JOUR AU - Sharabi, A. B. AU - Nirschl, C. J. AU - Kochel, C. M. PY - 2015 DA - 2015// TI - Stereotactic radiation therapy augments antigen-specific PD-1-mediated antitumor immune responses via cross-presentation of tumor antigen JO - Cancer Immunol Res VL - 3 ID - Sharabi2015 ER - TY - JOUR AU - Bauml, J. M. AU - Mick, R. AU - Ciunci, C. PY - 2019 DA - 2019// TI - Pembrolizumab after completion of locally ablative therapy for oligometastatic non-small cell lung cancer: a Phase 2 Trial JO - JAMA Oncol VL - 5 ID - Bauml2019 ER - TY - JOUR AU - Bersanelli, M. AU - Lattanzi, E. AU - D’Abbiero, N. PY - 2020 DA - 2020// TI - Palliative radiotherapy in advanced cancer patients treated with immune-checkpoint inhibitors: the PRACTICE study JO - Biomed Rep VL - 12 ID - Bersanelli2020 ER - TY - JOUR AU - Antonia, S. J. AU - Villegas, A. AU - Daniel, D. PY - 2017 DA - 2017// TI - Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer JO - N Engl J Med VL - 377 ID - Antonia2017 ER - TY - JOUR AU - Remark, R. AU - Merghoub, T. AU - Grabe, N. PY - 2016 DA - 2016// TI - In-depth tissue profiling using multiplexed immunohistochemical consecutive staining on single slide JO - Sci Immunol VL - 1 ID - Remark2016 ER - TY - JOUR AU - Le, D. T. AU - Uram, J. N. AU - Wang, H. PY - 2015 DA - 2015// TI - PD-1 blockade in tumors with mismatch-repair deficiency JO - N Engl J Med VL - 372 ID - Le2015 ER - TY - JOUR AU - Lee, J. AU - Kim, S. H. AU - Kim, G. PY - 2012 DA - 2012// TI - Treatment outcome in patients with vulvar cancer: comparison of concurrent radiotherapy to postoperative radiotherapy JO - Radiat Oncol J VL - 30 ID - Lee2012 ER - TY - JOUR AU - Barker, C. A. AU - Postow, M. A. AU - Kronenberg, S. A. AU - Ma, J. AU - Yamada, Y. AU - Beal, K. PY - 2015 DA - 2015// TI - Concurrent radiation therapy (RT), ipilimumab (Ipi) and/or nivolumab (nivo) on a phase 1 clinical trial [abstract] JO - Int J Radiat Oncol Biol Phys UR - https://doi.org/10.1016/j.ijrobp.2015.07.506 DO - 10.1016/j.ijrobp.2015.07.506 ID - Barker2015 ER - TY - JOUR AU - Duffy, A. G. AU - Kleiner, D. E. AU - Alewine, C. AU - Figg, W. D. AU - Steinberg, S. M. PY - 2017 DA - 2017// TI - A pilot study of immune checkpoint inhibition in combination with radiation therapy in patients with metastatic pancreatic cancer [abstract] JO - J Clin Oncol UR - https://doi.org/10.1200/jco.2017.35.4_suppl.316 DO - 10.1200/jco.2017.35.4_suppl.316 ID - Duffy2017 ER - TY - JOUR AU - Levy, A. AU - Massard, C. AU - Soria, J. C. AU - Deutsch, E. PY - 2016 DA - 2016// TI - Concurrent irradiation with the anti-programmed cell death ligand-1 immune checkpoint blocker durvalumab: single centre subset analysis from a phase 1/2 trial JO - Eur J Cancer VL - 68 ID - Levy2016 ER - TY - STD TI - Lin SH LY, Price J, Parker M, Gomez DR, Welsh JW, et al. DETERRED: PD-L1 blockade to evaluate the safety of lung cancer therapy using carboplatin, paclitaxel, and radiation combined with MPDL3280A (atezolizumab) [abstract]. J Clin Oncol 2017; 35:Abstr nr 3064. ID - ref34 ER - TY - JOUR AU - Tang, C. AU - Welsh, J. W. AU - Groot, P. PY - 2017 DA - 2017// TI - Ipilimumab with stereotactic ablative radiation therapy: Phase I results and immunologic correlates from peripheral T cells JO - Clin Cancer Res VL - 23 ID - Tang2017 ER - TY - JOUR AU - Luke, J. J. AU - Lemons, J. M. AU - Karrison, T. G. PY - 2018 DA - 2018// TI - Safety and clinical activity of pembrolizumab and multisite stereotactic body radiotherapy in patients with advanced solid tumors JO - J Clin Oncol VL - 36 ID - Luke2018 ER -